Evidence map›Paper›PMID 39026645›Full record

ReviewRSC medicinal chemistry2024

Molecular understanding of the therapeutic potential of melanin inhibiting natural products.

Meijun Pang, Ruitian Xu, Rongjiao Xi, Hong Yao, Kechen Bao, Rui Peng, Hui Zhi, Kuo Zhang, Runnan He, Yanfang Su and 2 more

Abstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Molecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Review
  6. Disrupting melanin transfer: innovative strategy for anti-pigmentation drug discovery.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Phenolic Glycoside Monomer fromCurrent medicinal chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Meijun PangMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Ruitian XuMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Rongjiao XiMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.ORCID https://orcid.org/0009-0007-7454-9118
Hong YaoMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Kechen BaoMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Rui PengMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Hui ZhiMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Kuo ZhangMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Runnan HeMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.
Yanfang SuDepartment of Neurosurgery, Tianjin Medical University General Hospital 154 Anshan Street, Heping District 300052 Tianjin China.
Xiuyun LiuMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.ORCID https://orcid.org/0000-0001-9540-4865
Dong MingMedical School, Tianjin University 92 Weijin Road, Nankai District 300072 Tianjin China Chinaxiuyun_liu@tju.edu.cn +(86) 13562488561.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the development of society and the improvement of people's living standards, there is an increasing demand for melanin-inhibiting products that prioritize health, safety, and efficacy. Therefore, the development of natural products that can safely and efficiently inhibit melanin synthesis is of great social significance and has significant market potential. In this paper, by reviewing the literature reported in recent years, we summarized the natural products with inhibition of melanin synthesis effects that have been put into or not yet put into the market, and classified them according to the chemical groups of their compounds or the extraction methods of the natural products. Through the summary analysis, we found that these compounds mainly include terpenoids, phenylpropanoids, flavonoids and so on, while the natural product extracts mainly include methanol extracts, ethanol extracts, and aqueous extracts. Their main inhibition of melanin synthesis mechanisms include: (1) direct inhibition of tyrosinase activity; (2) down-regulation of the α-MSH-MC1R, Wnt, NO, PI3K/Akt and MAPK pathways through the expression of MITF and its downstream genes TYR, TRP-1, and TRP-2; (3) antioxidant; (4) inhibition of melanocyte growth through cytotoxicity; (5) inhibition of melanosome production and transport. This paper provides an in-depth discussion on the research progress of whitening natural products and their market value. The aim is to offer guidance for future research and development of natural skin whitening products.

Identifiers

PMID39026645
PMCPMC11253861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.